Picture of OptimizeRx logo

OPRX — OptimizeRx News Story

0.000.00%
us flag iconLast trade - 00:00
TechnologyAdventurousSmall CapSuper Stock

Optimizerx Corp Expected To Post Earnings Of 21 Cents A Share: Earnings Preview

* OPTIMIZERx Corp  OPRX.OQ   OPRX.O  is expected to show a
rise in
quarterly revenue when it reports  results on February 24. 
    * The Rochester Michigan-based  company is expected to
report  a
22.7% increase in revenue to $20.159 million from $16.43 million
a year ago, according to the mean estimate from 5 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for OPTIMIZERx Corp is
for
earnings of 21 cents per share. For the same quarter last year,
the company reported earnings of 16 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for OPTIMIZERx
Corp
is $101​, about 56.5% above​ its last closing price
of $43.96. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2021  0.13        0.13       0.09      Missed  -31.8
 Jun. 30 2021  0.07        0.07       0.10      Beat    38.9
 Mar. 31 2021  -0.01       0.01       0.03      Beat    275​
 Dec. 31 2020  0.16        0.16       0.16      Met     3.2
 ​​Sep.        0.04        0.04       0.07      Beat    75
 30 2020                                                
 Jun. 30 2020  -0.03       -0.03      0.02      Beat    166.7​
 Mar. 31 2020  -0.03       -0.03      -0.06     Missed  -100
 Dec. 31 2019  0.00        0.01       -0.03     Missed  -700
 This summary was machine generated February 22 at 21:05 GMT. 
All figures in US dollars  unless otherwise stated

Recent news on OptimizeRx

See all news